Publication
Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC)
Conference Paper/Poster - Sep 28, 2015
Siano Marco
Units
Contact
Citation
Siano M (2015). Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC).
Type
Conference Paper/Poster (Deutsch)
Conference Name
ESMO 2015 (Wien)
Publisher Proceedings
Eur J Cancer 2015;51(suppl 3);S576. abstract 2861.
Publication Date
Sep 28, 2015
Pages
576
Publisher
Elsevier
Brief description/objective
Siano M, Molinari F, Martin V et al. Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC). Eur J Cancer 2015;51(suppl 3);S576. abstract 2861.